Navigation Links
Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
Date:9/10/2012

BUFFALO, N.Y., Sept. 10, 2012 /PRNewswire/ -- Kinex Pharmaceuticals, LLC announced the appointment of Mr. Patrick (Pat) Gallagher to the position of Vice President, Business Development and Investor Relations.  Mr. Gallagher will report to Johnson Lau, MBBS, MD, FRCP, Kinex's Chief Executive Officer.

"Pat joins Kinex's management team at a time when his experience will be invaluable to the strategic growth of Kinex," said Dr. Johnson Lau. "Having known Pat for 12 years, I am delighted to welcome his deep insight and expertise in the biotechnology space, which will be instrumental in helping us to plan for our next phase of company growth. He was an early investor in Kinex and we have enjoyed his many years of invaluable advice to the company."

"Pat's vast network in both the biotechnology space and Wall Street will be extremely useful in assisting us to navigate through the next stage of company development," stated Mr. Chuck Lannon, Vice President of the Board and Chair of the Nomination and Corporate Governance Committee. 

"This strong vote of confidence in Kinex and our pipeline from a Wall Street veteran such as Pat sends a powerful message about the strength of our team and the value of our products," said Dr. Jean-Pierre Sommadossi, Board member and Founder and former Chairman and CEO, Idenix.

Mr. Gallagher, CFA is an accomplished Capital Markets Executive, Advisor, and Investor with a distinguished record of success in both the public and private markets. He has nearly 20 years of experience on Wall Street and extensive expertise in alternative investments, capital markets, and marketing.  He is a founding partner and was CEO of BDR Research Group, LLC; a healthcare focused institutional research boutique specialized in providing services for clients in the healthcare investing, financing, and operations areas.  Mr. Gallagher is also a Managing Director of Potomac Management Group, a strategic consulting group. Prior, Mr. Gallagher worked for investment and research firms Kidder Peabody, PaineWebber and New Vernon Associates. 

About Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals, headquartered in Buffalo, New York, USA, is using its proprietary technologies Mimetica™ and Opal™ to discover and develop novel drugs for oncology and immune-modulatory diseases. More information of Kinex Pharmaceuticals can be found at www.kinexpharma.com  

Kinex Pharmaceuticals, LLC Caution Regarding Forward-looking Information

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Kinex Pharmaceuticals cautions investors that any forward-looking statements or projections made by Kinex Pharmaceuticals, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.

Contact:

Kinex Pharmaceuticals


Investors: Mr. Patrick Gallagher


e-mail: pgallagher@kinexpharma.com

 


'/>"/>
SOURCE Kinex Pharmaceuticals, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinex Pharmaceuticals Receives Substantial Strategic Investment
2. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
3. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
8. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
9. Actinium Pharmaceuticals Stockholders Vote to Approve Fundraising and Public Listing
10. Global Markets for Membrane Technology for Pharmaceuticals
11. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):